Variant report
Variant | nsv520604 |
---|---|
Chromosome Location | chr9:26546080-26551726 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12337751 | chr9:26546080-26546081 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs577948921 | chr9:26546083-26546084 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544444161 | chr9:26546128-26546129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539521647 | chr9:26546131-26546132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140753169 | chr9:26546138-26546139 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115017505 | chr9:26546166-26546167 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76075952 | chr9:26546231-26546232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560988920 | chr9:26546241-26546242 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2383696 | chr9:26546258-26546259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528445983 | chr9:26546280-26546281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10118730 | chr9:26546299-26546300 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs185042733 | chr9:26546310-26546311 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532617381 | chr9:26546338-26546339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544820719 | chr9:26546339-26546340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188334428 | chr9:26546358-26546359 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs386733844 | chr9:26546431-26546432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12337846 | chr9:26546432-26546433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73642953 | chr9:26546433-26546434 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs2148602 | chr9:26546480-26546481 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs553320692 | chr9:26546506-26546507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373219998 | chr9:26546563-26546564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200381180 | chr9:26546580-26546581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577980200 | chr9:26546605-26546606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531850657 | chr9:26546692-26546693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12337967 | chr9:26546715-26546716 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs148659481 | chr9:26546723-26546724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371652528 | chr9:26546728-26546729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372651629 | chr9:26546734-26546735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557080202 | chr9:26546735-26546736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575336904 | chr9:26546737-26546738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2182583 | chr9:26546738-26546739 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs375349215 | chr9:26546742-26546743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536387818 | chr9:26546744-26546745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201600200 | chr9:26546745-26546746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539220997 | chr9:26546756-26546757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373056781 | chr9:26546768-26546769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561029602 | chr9:26546835-26546836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181106660 | chr9:26546841-26546842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540205551 | chr9:26546857-26546858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs79457916 | chr9:26546869-26546870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186702699 | chr9:26546887-26546888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550979573 | chr9:26546895-26546896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148830948 | chr9:26546905-26546906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530213857 | chr9:26546907-26546908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549136114 | chr9:26546929-26546930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567336775 | chr9:26546936-26546937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534625198 | chr9:26546956-26546957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12551612 | chr9:26546985-26546986 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs115773877 | chr9:26547036-26547037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs114528012 | chr9:26547048-26547049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
polycythaemia | 22829968 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:26543200-26546800 | Weak transcription | Fetal Brain Male | brain |
2 | chr9:26546000-26546400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr9:26546400-26548000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr9:26548000-26549000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr9:26548000-26550000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr9:26548000-26550200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr9:26548200-26548600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr9:26548200-26548600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr9:26548200-26550000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr9:26548400-26549000 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr9:26548600-26552400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
12 | chr9:26548800-26549000 | Enhancers | Aorta | Aorta |
13 | chr9:26548800-26549400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr9:26549000-26550600 | Weak transcription | Aorta | Aorta |
15 | chr9:26550600-26553000 | Enhancers | Aorta | Aorta |